Targeting heat shock protein 90 with Ganetespib for the treatment of lymphoma

被引：0

作者：

Tu, Zhigang ^{[1
]}

Liu, Hanging ^{[1
]}

Zhao, Jingjing ^{[1
]}

Zhang, Peishan ^{[1
]}

Liang, Zhiquan ^{[1
]}

Ruan, Lingling ^{[1
]}

Lu, Yongjin ^{[1
]}

Shang, Dongsheng ^{[1
]}

Sun, Ying ^{[1
]}

Xu, Lili ^{[1
]}

Chen, Keping ^{[1
]}

Danzeng, Quji ^{[1
]}

机构：

[1] Jiangsu Univ, Zhenjiang, Peoples R China

来源：

CANCER RESEARCH | 2015年 / 75卷

关键词：

D O I：

10.1158/1538-7445.AM2015-2614

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2614

引用

页数：1

共 50 条

[31] Inhibition of Heat Shock Protein 90 as a Novel Platform for the Treatment of Cancer
Gao, Chan
Peng, Ya-Nan
Wang, Hai-Zhou
Fang, Shi-Lin
Zhang, Meng
Zhao, Qiu
Liu, Jing
CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (08) : 849 - 855
[32] Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors
Powers, Marissa V.
Workman, Paul
ENDOCRINE-RELATED CANCER, 2006, 13 : S125 - S135
[33] Nanomedicines Targeting Heat Shock Protein 90 Gene Expression in the Therapy of Breast Cancer
Zaib, Sumera
Areeba, B. S.
Rana, B. S. Nehal
Wattoo, Javed Iqbal
Alsaab, Hashem O.
Alzhrani, Rami M.
Awwad, Nasser S.
Ibrahium, Hala A.
Khan, Imtiaz
CHEMISTRYSELECT, 2022, 7 (14):
[34] Synthesis and activity of β-carboline antimalarials targeting the Plasmodium falciparum heat shock 90 protein
Viswanathan, Neil K.
Chirgwin, Michael E.
Gibbs, Julia
Kalaj, Brianna N.
Durham, Sierra
Tran, Jennifer
Gomez, Maximillian
Lazaro, Horacio
Chen, Ming
Mansfield, Christopher R.
Derbyshire, Emily R.
Eagon, Scott
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 92
[35] Global Targeting of Subcellular Heat Shock Protein-90 Networks for Therapy of Glioblastoma
Siegelin, Markus D.
Plescia, Janet
Raskett, Christopher M.
Gilbert, Candace A.
Ross, Alonzo H.
Altieri, Dario C.
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (06) : 1638 - 1646
[36] Analysis of mammalian Cdc37, a protein kinase targeting subunit of heat shock protein 90
Stepanova, L
Leng, XH
Harper, JW
CELL CYCLE CONTROL, 1997, 283 : 220 - 229
[37] UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib
Landmann, H.
Proia, D. A.
He, S.
Ogawa, L. S.
Kramer, F.
Beissbarth, T.
Grade, M.
Gaedcke, J.
Ghadimi, M.
Moll, U.
Dobbelstein, M.
CELL DEATH & DISEASE, 2014, 5 : e1411 - e1411
[38] A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer
Jhaveri, Komal
Chandarlapaty, Sarat
Lake, Diana
Gilewski, Teresa
Robson, Mark
Goldfarb, Shari
Drullinsky, Pamela
Sugarman, Steven
Wasserheit-Leiblich, Carolyn
Fasano, Julie
Moynahan, Mary Ellen
D'Andrea, Gabriella
Lim, Kristina
Reddington, Laura
Haque, Sofia
Patil, Sujata
Bauman, Lynne
Vukovic, Vojo
El-Hariry, Iman
Hudis, Clifford
Modi, Shanu
CLINICAL BREAST CANCER, 2014, 14 (03) : 154 - 160
[39] Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions
Hong, David S.
Banerji, Udai
Tavana, Bahareh
George, Goldy C.
Aaron, Joann
Kurzrock, Razelle
CANCER TREATMENT REVIEWS, 2013, 39 (04) : 375 - 387
[40] UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib
H Landmann
D A Proia
S He
L S Ogawa
F Kramer
T Beißbarth
M Grade
J Gaedcke
M Ghadimi
U Moll
M Dobbelstein
Cell Death & Disease, 2014, 5 : e1411 - e1411

← 1 2 3 4 5 →